A detailed history of Royal Fund Management, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Royal Fund Management, LLC holds 9,040 shares of TMO stock, worth $4.9 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares
9,040
Previous 4,258 112.31%
Holding current value
$4.9 Million
Previous $2.35 Million 137.51%
% of portfolio
0.34%
Previous 0.25%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$531.86 - $624.21 $2.54 Million - $2.98 Million
4,782 Added 112.31%
9,040 $5.59 Million
Q2 2024

Jul 18, 2024

BUY
$541.52 - $599.02 $151,625 - $167,725
280 Added 7.04%
4,258 $2.35 Million
Q1 2024

Apr 11, 2024

BUY
$528.82 - $599.43 $126,916 - $143,863
240 Added 6.42%
3,978 $2.31 Million
Q4 2023

Feb 06, 2024

BUY
$431.41 - $532.94 $170,406 - $210,511
395 Added 11.82%
3,738 $1.98 Million
Q3 2023

Oct 17, 2023

BUY
$498.29 - $574.41 $73,248 - $84,438
147 Added 4.6%
3,343 $1.69 Million
Q2 2023

Jul 12, 2023

BUY
$508.46 - $591.13 $72,201 - $83,940
142 Added 4.65%
3,196 $1.67 Million
Q1 2023

Apr 10, 2023

BUY
$535.0 - $604.82 $2,675 - $3,024
5 Added 0.16%
3,054 $1.76 Million
Q4 2022

Jan 20, 2023

BUY
$484.71 - $571.37 $24,720 - $29,139
51 Added 1.7%
3,049 $0
Q3 2022

Nov 14, 2022

SELL
$507.19 - $604.49 $33,981 - $40,500
-67 Reduced 2.19%
2,998 $1.52 Million
Q2 2022

Jul 28, 2022

SELL
$500.9 - $612.21 $56,100 - $68,567
-112 Reduced 3.53%
3,065 $1.67 Million
Q1 2022

May 13, 2022

BUY
$524.0 - $644.92 $3,144 - $3,869
6 Added 0.19%
3,177 $1.88 Million
Q4 2021

Feb 11, 2022

BUY
$569.0 - $667.24 $122,904 - $144,123
216 Added 7.31%
3,171 $2.12 Million
Q3 2021

Oct 20, 2021

BUY
$509.53 - $609.78 $151,839 - $181,714
298 Added 11.22%
2,955 $1.69 Million
Q2 2021

Jul 26, 2021

BUY
$441.0 - $508.24 $162,729 - $187,540
369 Added 16.13%
2,657 $1.34 Million
Q1 2021

Apr 29, 2021

BUY
$439.85 - $518.83 $221,684 - $261,490
504 Added 28.25%
2,288 $1.04 Million
Q4 2020

Feb 02, 2021

BUY
$435.06 - $527.66 $156,186 - $189,429
359 Added 25.19%
1,784 $830,000
Q3 2020

Oct 13, 2020

BUY
$359.77 - $441.52 $46,410 - $56,956
129 Added 9.95%
1,425 $629,000
Q2 2020

Aug 06, 2020

BUY
$275.2 - $362.34 $38,528 - $50,727
140 Added 12.11%
1,296 $469,000
Q1 2020

May 08, 2020

BUY
$255.3 - $340.05 $103,141 - $137,380
404 Added 53.72%
1,156 $327,000
Q4 2019

May 11, 2020

BUY
$271.93 - $328.04 $37,254 - $44,941
137 Added 22.28%
752 $244,000
Q3 2019

May 08, 2020

BUY
$268.46 - $305.43 $31,678 - $36,040
118 Added 23.74%
615 $179,000
Q2 2019

May 08, 2020

BUY
$257.51 - $295.55 $73,132 - $83,936
284 Added 133.33%
497 $145,000
Q3 2018

May 07, 2020

SELL
$205.57 - $244.32 $2,672 - $3,176
-13 Reduced 5.75%
213 $51,000
Q2 2018

May 07, 2020

BUY
$203.14 - $219.53 $1,421 - $1,536
7 Added 3.2%
226 $46,000
Q1 2018

May 07, 2020

BUY
$192.98 - $224.11 $1,157 - $1,344
6 Added 2.82%
219 $45,000
Q4 2017

May 07, 2020

BUY
$182.03 - $200.37 $2,366 - $2,604
13 Added 6.5%
213 $40,000
Q4 2016

May 07, 2020

BUY
N/A
200
200 $28,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $212B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Royal Fund Management, LLC Portfolio

Follow Royal Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Royal Fund Management, LLC with notifications on news.